STAGE IV PROSTATE CANCER AJCC V7
Clinical trials for STAGE IV PROSTATE CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PROSTATE CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV PROSTATE CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo aims to starve cancer cells in Late-Stage tumors
Disease control OngoingThis early-phase trial tests the safety and best dose of two drugs—MK-2206 and hydroxychloroquine—given together to people with advanced solid tumors, melanoma, prostate, or kidney cancer. The goal is to see if blocking certain cell signals and a process called autophagy can slow…
Matched conditions: STAGE IV PROSTATE CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New drug combo targets Hard-to-Treat prostate cancer
Disease control OngoingThis study tests a combination of two drugs—cabazitaxel (a chemotherapy) and enzalutamide (a hormone blocker)—in people with prostate cancer that has spread and stopped responding to standard hormone therapy. The goal is to find the safest dose and see if the combination can lowe…
Matched conditions: STAGE IV PROSTATE CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC